Completed PHASE2 INTERVENTIONAL NCT00321230

Clinical Evaluation of a New Reduced Volume Bowel Preparation

A Pilot Monocentric, Open Phase II Study to Investigate the Efficacy and Safety of a New Oral Gut Cleansing Solution (Low Dose Bowel Prep) in 30 Patients Submitted to Colonoscopy

Sponsor: Norgine

Conditions Colonoscopy

Interventions macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate

Updated 5 times since 2017 Last updated: Apr 15, 2008 Started: Jan 31, 2001 Completion: May 31, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00321230, this PHASE2 trial focuses on Colonoscopy and remains completed. Sponsored by Norgine, it has been updated 5 times since 2001, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Norgine

Data source: Norgine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France